Fabian Garcia sold 32,000 ADRs of Unilever
Fabian Garcia, group president of personal care, sold 32,000 American Depositary Receipts (ADR) of Unilever PLC on November 6, 2026. The total transaction value on the New York Stock Exchange was $2,119,136.00, marking a personal financial event for the executive.
Key points
- The sale was executed in two parts: 22,400 receipts at a price of $66.22 and 9,600 receipts at $66.23.
- The company filed a Form 144, a notice of a proposed sale of shares as required by regulators.
- Fabian Garcia is a member of Unilever leadership as group president of personal care.
Transaction terms
The sale was executed in two parts: 22,400 receipts at a price of $66.22 and 9,600 receipts at $66.23. The transaction was conducted on the New York Stock Exchange.
Sale notice
The company filed a Form 144, a notice of a proposed sale of shares as required by regulators. This form serves as a notice of intent, while the transaction was executed through broker Fidelity Brokerage Services LLC on November 6, 2026.
Seller and insider details
Fabian Garcia is a member of Unilever leadership as group president of personal care. His officer status is noted in the transaction report.
Missing information
Public company reports do not indicate financial or personal reasons for the sale of these receipts. The transaction concerns the executive's existing assets, and its impact on company operations is unconfirmed.
What to watch for
Shareholders should check regular insider reports and official company announcements to track any further changes in management.
Original sources
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Unilever
A notification in your browser or on your phone when we publish about Unilever. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
